Serum S100A12 (EN-RAGE) Levels in Patients with Decreased Renal Function and Subclinical Chronic Inflammatory Disease

Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients

(2010) A. Nakashima et al.   Clinical Journal of the American Society of Nephrology

C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: Inhibitory effects of atorvastatin

(2009) Nitin Mahajan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease

(2009) Giuseppina Basta et al.   KIDNEY INTERNATIONAL

Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis

(2008) Yasukiyo Mori et al.   AMERICAN JOURNAL OF NEPHROLOGY

Plasma S100A12 Concentrations in Peritoneal Dialysis Patients and Subclinical Chronic Inflammatory Disease

(2008) Yoko Uchiyama-Tanaka et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications

(2007) Giuseppina Basta   ATHEROSCLEROSIS